Balance Sheets - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current Assets:
Cash	$ 341	$ 461
Prepaid expenses	45,012	95,182
Total current assets	45,353	95,643
Cash and marketable securities held in trust	18,421,078	17,876,466
TOTAL ASSETS	18,466,431	17,972,109
Current liabilities:
Accrued expenses	24,820	72,838
Amount due to Sponsor	1,001,144	384,050
Total Current Liabilities	1,025,964	456,888
Deferred underwriting compensation	690,000	690,000
TOTAL LIABILITIES	1,715,964	1,146,888
Commitments and contingencies (Note 7)
Ordinary shares subject to possible redemption, 1,652,509 shares (at redemption price of $11.15 and $10.82 per share) at June 30, 2026 and December 31, 2025, respectively	18,421,078	17,876,466
Shareholders’ deficit:
Ordinary shares, par value $0.0001 per share; 500,000,000 shares authorized; 2,000,900 and 2,000,900 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively	200	200
Additional paid-in capital
Share capital receivable
Accumulated deficit	(1,670,811)	(1,051,445)
Total Shareholders’ deficit	(1,670,611)	(1,051,245)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT	$ 18,466,431	$ 17,972,109

Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Name:	us-gaap_AccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.